Bempedoic acid
Esperion
[]
now in the late-breaking clinical trials session at #acc2023, nissen and colleagues reveal significant reductions in mi (23%) and coronary revascularization (19%) with bempedoic acid. #clear-outcomes 
Cardiovascular Medicine Fellow @BrighamWomens @HarvardMed | Research Fellow @TIMIStudyGroup | Forbes 30 Under 30 | Proud Alum @Caltech